Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
920-CGS-200 in Osteoarthritis Knee Pain
NCT03124407Phase 4Completed
- Sponsor
- Propella Therapeutics
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of capsaicin 8% patch in osteoarthritis (OA), sponsored by Propella Therapeutics. Started Jul 2016; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03124407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124407.